As far as nationally-authorised med- icinal products are concerned, on the basis of existing CPMP opinions, the Commission notified decisions pursuant to Article 14 of Council Directive 75/ 319/ EEC for naftidrofuryl (Official Journal No C.216/ 8, 26.7.96) and for sparfloxacin (Official Journal